Serina Therapeutics Inc Share Price

NYSE: SER

Small Cap

$4.82

-0.21

(-4.08%)

as on September 18, 2025 at 1:29 am IST

$₹

Serina Therapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$4.81
Day's Price Range
$5
$4.82
0.21%
Downside
3.73%
Upside
52 Week's Low
52 Week's High
$3.81
52-Week Price Range
$10.28
$4.82
20.95%
Downside
113.28%
Upside

Serina Therapeutics Inc share price movements today

Previous Close: $5.03
Open: $5.00
Volume: 308.4K
Day's Low - High: $4.81 - $5
52 Week Low - High: $3.81 - $10.28

Serina Therapeutics Inc Historical Returns

1 Month Return: -3.83 %
3 Month Return: -12.61 %
1 Year Return: -16.39 %
3 Year Return: 0 %
5 Year Return: 0 %

Serina Therapeutics Inc Stock Fundamentals & Key Indicators

Check Serina Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$51.5M

EPS (TTM)

-2.13

Dividend Yield

0.00%

PE Ratio (TTM)

-5.42

Industry PE ratio

P/B Ratio

PEG Ratio

Return On Equity TTM

54024300.00%

Serina Therapeutics Inc Stock Valuation

Track how Serina Therapeutics Inc P/E has moved over time to understand its valuation trends.

Serina Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 18, 2025

Industry (0.00x)

September 18, 2025

Today (-5.42x)

September 18, 2025

Highest (-0.89x)

June 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -5.42x

Serina Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Serina Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Serina Therapeutics Inc	NA	$51.5M	NA	-5.42	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	248.74%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Serina Therapeutics Inc Stock including INR - Dollar returns

The Serina Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Serina Therapeutics Inc investment value today

Current value as on today

₹84,798

Returns

₹15,202

(-15.2%)

Returns from Serina Therapeutics Inc Stock

₹19,800 (-19.8%)

Dollar Returns*

₹4,598 (+4.6%)

Serina Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Serina Therapeutics Inc Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-4% versus previous 30 day period

Serina Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	3	0	0	0	0	-	0
Gross Profit	0	0	0	3	0	0	0	0	0	0
Operating Income	-2	-1	-1	0	-2	-3	-5	-5	-5	-5
EBITDA	-2	-1	1	1	-9	5	1	-2	-4	-6
Interest Expense	0	0	0	0	0	0	0	0	-	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	-2	1	1	-9	5	1	-2	-4	-6
Income Tax Expense	0	0	0	0	0	0	-	-	-	-
Net Income	-3	-2	-5	-3	-9	5	1	-2	-4	-6
Net Profit Margin	-32770.00%	-29655.56%	-8061.19%	-112.68%	-188740.00%	10203.92%	10071.43%	19571.43%	0.00%	-4960.00%

Serina Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Jun 2020	Dec 2020	Jun 2021	Dec 2021	Jun 2022	Dec 2022	Jun 2023	Dec 2023	Dec 2024
Total Revenue	1	1	0	0	3	3	0	0	3	0
Gross Profit	0	-	-1	-	0	-	0	-	3	0
Operating Income	-12	-	-10	-	-1	-	-2	-	-3	-17
EBITDA	-11	-	-8	-	-7	-	-7	-	5	-10
Interest Expense	-	-	0	-	0	-	0	-	0	0
Depreciation	-	-	-	-	0	-	0	-	0	0
Income Before Tax	-12	-	-10	-	-1	-	-2	-	5	-11
Income Tax Expense	0	-	0	-	0	-	0	-	0	-
Net Income	-12	-12	-10	-10	-1	-1	-2	-2	5	-11
Net Profit Margin	-703.36%	-703.36%	-20120.37%	-20120.37%	-41.61%	-41.61%	-536.42%	-536.42%	167.11%	-19894.64%

Serina Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-2	-5	-3	-9	5	1	-2	-4	-6
Operating Cash Flow	-2	-1	0	-1	-8	-2	-4	-4	-3
Investing Cash Flow	0	0	0	0	-	0	0	-	0
Financing Cash Flow	2	0	0	2	5	0	5	4	5
Change in Cash	0	0	7	1	-2	-2	0	0	1

Serina Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-6	-7	-12	-10	-1	-2	5	-11
Operating Cash Flow	-6	-7	-10	-7	-2	-2	-2	-17
Investing Cash Flow	0	1	0	0	0	0	0	0
Financing Cash Flow	13	6	6	5	1	1	10	13
Change in Cash	7	0	-4	-1	0	0	7	-3

Insights on Serina Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, -14.0K → 130.0K (in $), with an average increase of 110.8% per quarter
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 89.9%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 5 quarters, 5.20M → -6.44M (in $), with an average decrease of 119.2% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, SER stock has moved down by -7.5%

About Serina Therapeutics Inc

agex therapeutics, inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the united states. the company's lead cell-based therapeutic candidates in development include agex-bat1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as type ii adult-onset diabetes; and agex-vasc1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as the ischemic heart. its lead drug-based therapeutic candidate in discovery is agex-itr1547, a drug-based formulation to restore regenerative potential in a range of aged tissues afflicted with degenerative diseases. in addition, the company markets human embryonic stem cells; and genecards database suite, including genomic interpretation algorithms and analysis tools for use by researchers at pharmaceutical and biotechnology companies, and other institutions. agex therapeutics, inc. ha

Organisation	Serina Therapeutics Inc
Headquarters	601 Genome Way, Huntsville, AL, United States, 35806
CEO	Mr. Steven A. Ledger
E-voting on shares	Click here to vote

Key Management of Serina Therapeutics Inc

Name	Title
Dr. Balkrishan Gill Ph.D.	Executive Chairman
Mr. Steven A. Ledger	CEO & Director
Dr. J. Milton Harris Ph.D.	Co-Founder, Director Emeritus & Chair of Scientific Advisory Board
Mr. Gregory S. Curhan	Chief Financial Officer
Dr. Srini Tenjarla	Senior Vice President of Chemistry, Manufacturing & Controls and Formulation
Dr. Randall W. Moreadith M.D., Ph.D.	Chief Development Officer

FAQs

What is Serina Therapeutics Inc share price today?

Serina Therapeutics Inc share price today is $4.82 as on September 18, 2025 at 1:29 am IST at the close of the market. Serina Therapeutics Inc share today touched a day high of $5 and a low of $4.81.

What is the 52 week high and 52 week low for Serina Therapeutics Inc share?

Serina Therapeutics Inc share touched a 52 week high of $10.28 on September 23, 2024 and a 52 week low of $3.81 on November 8, 2024. Serina Therapeutics Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $4.82,which is 53.11% down from its 52 week high and 26.51% up from its 52 week low.

What is Serina Therapeutics Inc's market capitalisation today?

Serina Therapeutics Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Serina Therapeutics Inc Stock (SER) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Serina Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Serina Therapeutics Inc Shares that will get you 0.3112 shares as per Serina Therapeutics Inc share price of $4.82 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Serina Therapeutics Inc Stock (SER) from India?

Indian investors can start investing in Serina Therapeutics Inc (SER) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 1:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Serina Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 1:41 pm IST). Based on Serina Therapeutics Inc share’s latest price of $4.82 as on September 18, 2025 at 1:29 am IST, you will get 2.0747 shares of Serina Therapeutics Inc. Learn more about fractional shares .